Stablecoin issuer Tether has invested $200 million in biotech company Blackrock Neurotech. The investment was made through Tether Evo, Tether's newly formed venture capital arm. With this investment, Tether is now a majority shareholder in Blackrock Neurotech.
Tether added that the investment will help Blackrock Neurotech fund the commercialization and rollout of its medical solutions and support its research and development efforts.
Tether invests $200 million in biotech firm Blackrock Neurotech
2024-04-29 13:04:31
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
4月29日晚间重要动态一览
